AF
MRK icon

Apollon Financial’s Merck MRK Stock Holding History

Apollon Financial’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$581K Sell
4,521
-44
-1% -$5.15K 0.07% 188
2026
Q1 		$549K Buy
4,565
+103
+2% +$11.9K 0.08% 174
2025
Q4 		$470K Buy
4,462
+724
+19% +$68K 0.07% 180
2025
Q3 		$314K Buy
3,738
+641
+21% +$52.8K 0.05% 194
2025
Q2 		$245K Buy
3,097
+29
+0.9% +$2.31K 0.05% 193
2025
Q1 		$275K Buy
3,068
+309
+11% +$28.9K 0.06% 175
2024
Q4 		$274K Buy
2,759
+704
+34% +$72.6K 0.07% 164
2024
Q3 		$233K Buy
2,055
+390
+23% +$46.3K 0.07% 152
2024
Q2 		$206K Hold
1,665
– – 0.07% 140
2024
Q1 		$220K Buy
+1,665
New +$205K 0.08% 140

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Apollon Financial's MRK Position: Q2 2026 in Review

Apollon Financial reduced its Merck (MRK) stake by 0.96% in Q2 2026, selling an estimated $5.15K and leaving 4,521 shares worth $581K. The position accounts for 0.07% of the portfolio, ranked #188.

Apollon Financial first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Apollon Financial held 4,521 shares of Merck worth $581K as of Q2 2026.
  • Apollon Financial sold 44 Merck shares in Q2 2026, an estimated $5.15K.
  • Merck made up 0.07% of Apollon Financial's portfolio in Q2 2026, its #188 holding.
  • Apollon Financial first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Apollon Financial's 13F filing for Q2 2026, filed 23 Jul 2026.